A standard heart ultrasound scan, called transthoracic echocardiography (TTE), may help screen for cardiac sarcoidosis when used alongside symptoms and heart rhythm tests, a study found. Adding heart strain imaging or three-dimensional echocardiography did not appear to significantly improve its overall diagnostic value. Although TTE had low sensitivity,…

Black/African American people with sarcoidosis are more likely than non-Hispanic white patients to develop certain eye problems, including inflammation in the front of the eye and nerve damage, a study shows. In contrast, white sarcoidosis patients were found to have a higher risk of inflammation in the back part…

Comparing levels of a protein known as ACE, fully, angiotensin-converting enzyme, in urine and blood may help diagnose renal sarcoidosis and assess how severely the kidneys are affected, according to a retrospective analysis of data from a single center in Japan. The findings suggest that measuring ACE levels in…

To mark Sarcoidosis Awareness Month, celebrated each April, the Foundation for Sarcoidosis Research (FSR) has launched a global campaign that was sparked by a kaleidoscope. This year’s awareness initiative — dubbed “See Sarcoidosis” — is designed to spotlight the many presentations of sarcoidosis, which affects each patient differently,…

While sarcoidosis can lead to hospital admission, in-hospital deaths among people with sarcoidosis are most often caused by other conditions rather than the disease itself, according to a real-world national study in Spain. Common causes of death included infections, cardiovascular disease, cancer, and blood clots known as venous thromboembolism…

People with pulmonary sarcoidosis who are older at diagnosis or have more severe lung damage may face a higher risk of death. That’s according to a large study from Spain, in which researchers found that being older than 50 and having a Composite Physiological Index (CPI) score above 35…

People with autoimmune diseases — especially Sjögren’s disease, which affects the glands that produce tears and saliva — may have a significantly higher risk of developing sarcoidosis, according to a study in Japan. The strongest association was seen with Sjögren’s disease, while other autoimmune conditions were also significantly linked…

Atyr Pharma will meet with the U.S. Food and Drug Administration (FDA) next month to review results from the Phase 3 EFZO-FIT clinical trial and discuss the path forward for efzofitimod as a treatment for pulmonary sarcoidosis. The meeting follows a company announcement last year that the trial…

A bipartisan group of U.S. lawmakers is joining forces to form a new team — the Congressional Sarcoidosis Caucus — to help lead a nationwide fight against sarcoidosis, a rare disease that can affect any of the body’s organs. The newly formed caucus will work to raise awareness about…

The Sarcoidosis Research Institute (SRI) will host a free virtual conference in April aimed at empowering people affected by sarcoidosis. The conference, called Empowering the Patient Journey: Living Well with Sarcoidosis, will take place from 1 to 5 p.m. EST April 25. It will feature expert-led presentations and…